Skip to main content
Erschienen in: Acta Neuropathologica 1/2011

01.01.2011 | Review

Genetic Creutzfeldt–Jakob disease and fatal familial insomnia: insights into phenotypic variability and disease pathogenesis

verfasst von: Sabina Capellari, Rosaria Strammiello, Daniela Saverioni, Hans Kretzschmar, Piero Parchi

Erschienen in: Acta Neuropathologica | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Human prion diseases are a group of rare neurodegenerative disorders characterized by the conversion of the constitutively expressed prion protein, PrPC, into an abnormally aggregated isoform, called PrPSc. While most people who develop a prion disease have no identifiable cause and a few acquire the disease through an identified source of infection, about 10–15% of patients are affected by a genetic form and carry either a point mutation or an insertion of octapeptide repeats in the prion protein gene. Prion diseases show the highest extent of phenotypic heterogeneity among neurodegenerative disorders and comprise three major disease entities with variable though overlapping phenotypic features: Creutzfeldt–Jakob disease (CJD), fatal insomnia and the Gerstmann–Sträussler–Scheinker syndrome. Both CJD and fatal insomnia are fully transmissible diseases, a feature that led to the isolation and characterization of different strains of the agent or prion showing distinctive clinical and neuropathological features after transmission to syngenic animals. Here, we review the current knowledge of the effects of the pathogenic mutations linked to genetic CJD and fatal familial insomnia on the prion protein metabolism and physicochemical properties, the disease phenotype and the strain characteristics. The data derived from studies in vitro and from those using cell and animal models are compared with those obtained from the analyses of the naturally occurring disease. The extent of phenotypic variation in genetic prion disease is analyzed in comparison to that of the sporadic disease, which has recently been the topic of a systematic and detailed characterization.
Literatur
1.
Zurück zum Zitat Antoine JC, Laplanche JL, Mosnier JF, Beaudry P, Chatelain J, Michel D (1996) Demyelinating peripheral neuropathy with Creutzfeldt–Jakob disease and mutation at codon 200 of the prion protein gene. Neurology 46:1123–1127PubMed Antoine JC, Laplanche JL, Mosnier JF, Beaudry P, Chatelain J, Michel D (1996) Demyelinating peripheral neuropathy with Creutzfeldt–Jakob disease and mutation at codon 200 of the prion protein gene. Neurology 46:1123–1127PubMed
2.
Zurück zum Zitat Apetri AC, Surewicz K, Surewicz WK (2004) The effect of disease-associated mutations on the folding pathway of human prion protein. J Biol Chem 279:18008–18014PubMedCrossRef Apetri AC, Surewicz K, Surewicz WK (2004) The effect of disease-associated mutations on the folding pathway of human prion protein. J Biol Chem 279:18008–18014PubMedCrossRef
3.
Zurück zum Zitat Apetri AC, Vanik DL, Surewicz WK (2005) Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein 90–231. Biochemistry 44:15880–15888PubMedCrossRef Apetri AC, Vanik DL, Surewicz WK (2005) Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein 90–231. Biochemistry 44:15880–15888PubMedCrossRef
4.
Zurück zum Zitat Asante EA, Gowland I, Grimshaw A et al (2009) Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins. J Gen Virol 90:546–558PubMedCrossRef Asante EA, Gowland I, Grimshaw A et al (2009) Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins. J Gen Virol 90:546–558PubMedCrossRef
5.
Zurück zum Zitat Ashok A, Hegde RS (2009) Selective processing and metabolism of disease-causing mutant prion proteins. PLoS Pathog 5:e1000479PubMedCrossRef Ashok A, Hegde RS (2009) Selective processing and metabolism of disease-causing mutant prion proteins. PLoS Pathog 5:e1000479PubMedCrossRef
6.
Zurück zum Zitat Baldin E, Capellari S, Provini F et al (2009) A case of fatal familial insomnia in Africa. J Neurol 256:1778–1779PubMedCrossRef Baldin E, Capellari S, Provini F et al (2009) A case of fatal familial insomnia in Africa. J Neurol 256:1778–1779PubMedCrossRef
7.
Zurück zum Zitat Bamdad K, Naderi-Manesh H (2007) Contribution of a putative salt bridge and backbone dynamics in the structural instability of human prion protein upon R208H mutation. Biochem Biophys Res Commun 364:719–724PubMedCrossRef Bamdad K, Naderi-Manesh H (2007) Contribution of a putative salt bridge and backbone dynamics in the structural instability of human prion protein upon R208H mutation. Biochem Biophys Res Commun 364:719–724PubMedCrossRef
8.
Zurück zum Zitat Barducci A, Chelli R, Procacci P, Schettino V (2005) Misfolding pathways of the prion protein probed by molecular dynamics simulations. Biophys J 88:1334–1343PubMedCrossRef Barducci A, Chelli R, Procacci P, Schettino V (2005) Misfolding pathways of the prion protein probed by molecular dynamics simulations. Biophys J 88:1334–1343PubMedCrossRef
9.
Zurück zum Zitat Baron T, Bencsik A, Vulin J et al (2008) A C-terminal protease-resistant prion fragment distinguishes ovine “CH1641-like” scrapie from bovine classical and L-Type BSE in ovine transgenic mice. PLoS Pathog 4:e1000137PubMedCrossRef Baron T, Bencsik A, Vulin J et al (2008) A C-terminal protease-resistant prion fragment distinguishes ovine “CH1641-like” scrapie from bovine classical and L-Type BSE in ovine transgenic mice. PLoS Pathog 4:e1000137PubMedCrossRef
10.
Zurück zum Zitat Barron RM, Thomson V, Jamieson E et al (2001) Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriers. EMBO J 20:5070–5078PubMedCrossRef Barron RM, Thomson V, Jamieson E et al (2001) Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriers. EMBO J 20:5070–5078PubMedCrossRef
11.
Zurück zum Zitat Basset-Leobon C, Uro-Coste E, Peoc’h K et al (2006) Familial Creutzfeldt–Jakob disease with an R208H–129V haplotype and kuru plaques. Arch Neurol 63:449–452PubMedCrossRef Basset-Leobon C, Uro-Coste E, Peoc’h K et al (2006) Familial Creutzfeldt–Jakob disease with an R208H–129V haplotype and kuru plaques. Arch Neurol 63:449–452PubMedCrossRef
12.
Zurück zum Zitat Beck JA, Mead S, Campbell TA et al (2001) Two-octapeptide repeat deletion of prion protein associated with rapidly progressive dementia. Neurology 57:354–356PubMed Beck JA, Mead S, Campbell TA et al (2001) Two-octapeptide repeat deletion of prion protein associated with rapidly progressive dementia. Neurology 57:354–356PubMed
13.
Zurück zum Zitat Bessen RA, Marsh RF (1994) Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 68:7859–7868PubMed Bessen RA, Marsh RF (1994) Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 68:7859–7868PubMed
14.
Zurück zum Zitat Bishop MT, Hart P, Aitchison L et al (2006) Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol 5:393–398PubMedCrossRef Bishop MT, Hart P, Aitchison L et al (2006) Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol 5:393–398PubMedCrossRef
15.
Zurück zum Zitat Bishop MT, Will RG, Manson JC (2010) Defining sporadic Creutzfeldt–Jakob disease strains and their transmission properties. Proc Natl Acad Sci USA 107:12005–12010PubMedCrossRef Bishop MT, Will RG, Manson JC (2010) Defining sporadic Creutzfeldt–Jakob disease strains and their transmission properties. Proc Natl Acad Sci USA 107:12005–12010PubMedCrossRef
16.
Zurück zum Zitat Brown P, Goldfarb LG, Gibbs CJ, Gajdusek DC (1991) The phenotypic expression of different mutations in transmissible familial Creutzfeldt–Jakob disease. Eur J Epidemiol 7:469–476PubMedCrossRef Brown P, Goldfarb LG, Gibbs CJ, Gajdusek DC (1991) The phenotypic expression of different mutations in transmissible familial Creutzfeldt–Jakob disease. Eur J Epidemiol 7:469–476PubMedCrossRef
17.
Zurück zum Zitat Brown P, Goldfarb LG, Kovanen J et al (1992) Phenotypic characteristics of familial Creutzfeldt–Jakob disease associated with the codon 178Asn PRNP mutation. Ann Neurol 31:282–285PubMedCrossRef Brown P, Goldfarb LG, Kovanen J et al (1992) Phenotypic characteristics of familial Creutzfeldt–Jakob disease associated with the codon 178Asn PRNP mutation. Ann Neurol 31:282–285PubMedCrossRef
18.
Zurück zum Zitat Bruce ME (1993) Scrapie strain variation and mutation. Br Med Bull 49:822–838PubMed Bruce ME (1993) Scrapie strain variation and mutation. Br Med Bull 49:822–838PubMed
19.
Zurück zum Zitat Bruce ME, Will RG, Ironside JW et al (1997) Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature 389:498–501PubMedCrossRef Bruce ME, Will RG, Ironside JW et al (1997) Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature 389:498–501PubMedCrossRef
20.
Zurück zum Zitat Calzolai L, Zahn R (2003) Influence of pH on NMR structure and stability of the human prion protein globular domain. J Biol Chem 278:35592–35596PubMedCrossRef Calzolai L, Zahn R (2003) Influence of pH on NMR structure and stability of the human prion protein globular domain. J Biol Chem 278:35592–35596PubMedCrossRef
21.
Zurück zum Zitat Campana V, Sarnataro D, Fasano C, Casanova P, Paladino S, Zurzolo C (2006) Detergent-resistant membrane domains but not the proteasome are involved in the misfolding of a PrP mutant retained in the endoplasmic reticulum. J Cell Sci 119:433–442PubMedCrossRef Campana V, Sarnataro D, Fasano C, Casanova P, Paladino S, Zurzolo C (2006) Detergent-resistant membrane domains but not the proteasome are involved in the misfolding of a PrP mutant retained in the endoplasmic reticulum. J Cell Sci 119:433–442PubMedCrossRef
22.
Zurück zum Zitat Capellari S, Vital C, Parchi P et al (1997) Familial prion disease with a 144 bp insertion in the prion protein gene in a Basque family. Neurology 49:133–141PubMed Capellari S, Vital C, Parchi P et al (1997) Familial prion disease with a 144 bp insertion in the prion protein gene in a Basque family. Neurology 49:133–141PubMed
23.
Zurück zum Zitat Capellari S, Zaidi SI, Long AC, Kwon EE, Petersen RB (2000) The thr183ala mutation, not the loss of the first glycosylation site, alters the physical properties of the prion protein. J Alzheimers Dis 2:27–35PubMed Capellari S, Zaidi SI, Long AC, Kwon EE, Petersen RB (2000) The thr183ala mutation, not the loss of the first glycosylation site, alters the physical properties of the prion protein. J Alzheimers Dis 2:27–35PubMed
24.
Zurück zum Zitat Capellari S, Parchi P, Russo CM (2000) Effect of the E200K mutation on prion protein metabolism. Comparative study of a cell model and human brain. Am J Pathol 157:613–622PubMed Capellari S, Parchi P, Russo CM (2000) Effect of the E200K mutation on prion protein metabolism. Comparative study of a cell model and human brain. Am J Pathol 157:613–622PubMed
25.
Zurück zum Zitat Capellari S, Parchi P, Wolff BD et al (2002) Creutzfeldt–Jakob disease associated with a deletion of two repeats in the prion protein gene. Neurology 59:1628–1630PubMed Capellari S, Parchi P, Wolff BD et al (2002) Creutzfeldt–Jakob disease associated with a deletion of two repeats in the prion protein gene. Neurology 59:1628–1630PubMed
26.
Zurück zum Zitat Capellari S, Cardone F, Notari S et al (2005) Creutzfeldt–Jakob disease associated with the R208H mutation in the prion protein gene. Neurology 64:905–907PubMed Capellari S, Cardone F, Notari S et al (2005) Creutzfeldt–Jakob disease associated with the R208H mutation in the prion protein gene. Neurology 64:905–907PubMed
27.
Zurück zum Zitat Cardone F, Liu QG, Petraroli R et al (1999) Prion protein glycotype analysis in familial and sporadic Creutzfeldt–Jakob disease patients. Brain Res Bull 6:429–433CrossRef Cardone F, Liu QG, Petraroli R et al (1999) Prion protein glycotype analysis in familial and sporadic Creutzfeldt–Jakob disease patients. Brain Res Bull 6:429–433CrossRef
28.
Zurück zum Zitat Caughey B, Race RE, Ernst D, Buchmeier MJ, Chesebro B (1989) Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells. J Virol 63:175–181PubMed Caughey B, Race RE, Ernst D, Buchmeier MJ, Chesebro B (1989) Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells. J Virol 63:175–181PubMed
29.
Zurück zum Zitat Chapman J, Ben-Israel J, Goldhammer Y, Korczyn AD (1994) The risk of developing Creutzfeldt–Jakob disease in subjects with the PRNP gene codon 200 point mutation. Neurology 44:1683–1686PubMed Chapman J, Ben-Israel J, Goldhammer Y, Korczyn AD (1994) The risk of developing Creutzfeldt–Jakob disease in subjects with the PRNP gene codon 200 point mutation. Neurology 44:1683–1686PubMed
30.
Zurück zum Zitat Chasseigneaux S, Haïk S, Laffont-Proust I et al (2006) V180I mutation of the prion protein gene associated with atypical PrPSc glycosylation. Neurosci Lett 408:165–169PubMedCrossRef Chasseigneaux S, Haïk S, Laffont-Proust I et al (2006) V180I mutation of the prion protein gene associated with atypical PrPSc glycosylation. Neurosci Lett 408:165–169PubMedCrossRef
31.
Zurück zum Zitat Chen SG, Parchi P, Brown P et al (1997) Allelic origin of the abnormal prion proteins in familial prion diseases. Nat Med 3:1009–1015PubMedCrossRef Chen SG, Parchi P, Brown P et al (1997) Allelic origin of the abnormal prion proteins in familial prion diseases. Nat Med 3:1009–1015PubMedCrossRef
32.
Zurück zum Zitat Chesebro B (2003) Introduction to the transmissible spongiform encephalopathies or prion diseases. Br Med Bull 66:1–20PubMedCrossRef Chesebro B (2003) Introduction to the transmissible spongiform encephalopathies or prion diseases. Br Med Bull 66:1–20PubMedCrossRef
33.
Zurück zum Zitat Chiesa R, Piccardo P, Ghetti B, Harris DA (1998) Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. Neuron 21:1339–1351PubMedCrossRef Chiesa R, Piccardo P, Ghetti B, Harris DA (1998) Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. Neuron 21:1339–1351PubMedCrossRef
34.
Zurück zum Zitat Chiesa R, Pestronk A, Schmidt RE et al (2001) Primary myopathy and accumulation of PrPSc-like molecules in peripheral tissues of transgenic mice expressing a prion protein insertional mutation. Neurobiol Dis 8:279–288PubMedCrossRef Chiesa R, Pestronk A, Schmidt RE et al (2001) Primary myopathy and accumulation of PrPSc-like molecules in peripheral tissues of transgenic mice expressing a prion protein insertional mutation. Neurobiol Dis 8:279–288PubMedCrossRef
35.
Zurück zum Zitat Chiti F, Dobson CM (2006) Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75:333–366PubMedCrossRef Chiti F, Dobson CM (2006) Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75:333–366PubMedCrossRef
36.
Zurück zum Zitat Choi CJ, Kanthasamy A, Anantharam V, Kanthasamy AG (2006) Interaction of metals with prion protein: possible role of divalent cations in the pathogenesis of prion diseases. Neurotoxicology 27:777–787PubMedCrossRef Choi CJ, Kanthasamy A, Anantharam V, Kanthasamy AG (2006) Interaction of metals with prion protein: possible role of divalent cations in the pathogenesis of prion diseases. Neurotoxicology 27:777–787PubMedCrossRef
37.
Zurück zum Zitat Clerici F, Elia A, Girotti F et al (2008) Atypical presentation of CJD: the first Italian case associated with E196K mutation in the PRNP gene. J Neurol Sci 275:145–147PubMedCrossRef Clerici F, Elia A, Girotti F et al (2008) Atypical presentation of CJD: the first Italian case associated with E196K mutation in the PRNP gene. J Neurol Sci 275:145–147PubMedCrossRef
38.
Zurück zum Zitat Cochran EJ, Bennett DA, Cervenakova L et al (1996) Familial Creutzfeldt–Jakob disease with a five-repeat octapeptide insert mutation. Neurology 47:727–733PubMed Cochran EJ, Bennett DA, Cervenakova L et al (1996) Familial Creutzfeldt–Jakob disease with a five-repeat octapeptide insert mutation. Neurology 47:727–733PubMed
39.
Zurück zum Zitat Cohen FE, Pan KM, Huang Z, Baldwin M, Fletterick RJ, Prusiner SB (1994) Structural clues to prion replication. Science 264:530–531PubMedCrossRef Cohen FE, Pan KM, Huang Z, Baldwin M, Fletterick RJ, Prusiner SB (1994) Structural clues to prion replication. Science 264:530–531PubMedCrossRef
40.
Zurück zum Zitat Collins S, Boyd A, Fletcher A et al (2000) Novel prion protein gene mutation in an octogenarian with CJD. Arch Neurol 57:1058–1063PubMedCrossRef Collins S, Boyd A, Fletcher A et al (2000) Novel prion protein gene mutation in an octogenarian with CJD. Arch Neurol 57:1058–1063PubMedCrossRef
41.
Zurück zum Zitat D’Alessandro M, Petraroli R, Ladogana A, Pocchiari M (1998) High incidence of Creutzfeldt–Jakob disease in rural Calabria, Italy. Lancet 352:1989–1990PubMedCrossRef D’Alessandro M, Petraroli R, Ladogana A, Pocchiari M (1998) High incidence of Creutzfeldt–Jakob disease in rural Calabria, Italy. Lancet 352:1989–1990PubMedCrossRef
42.
Zurück zum Zitat Dossena S, Imeri L, Mangieri M et al (2008) Mutant prion protein expression causes motor and memory deficits and abnormal sleep patterns in a transgenic mouse model. Neuron 60:598–609PubMedCrossRef Dossena S, Imeri L, Mangieri M et al (2008) Mutant prion protein expression causes motor and memory deficits and abnormal sleep patterns in a transgenic mouse model. Neuron 60:598–609PubMedCrossRef
43.
Zurück zum Zitat Drisaldi B, Stewart RS, Adles C et al (2003) Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation. J Biol Chem 278:21732–21743PubMedCrossRef Drisaldi B, Stewart RS, Adles C et al (2003) Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation. J Biol Chem 278:21732–21743PubMedCrossRef
44.
Zurück zum Zitat Endo T, Groth D, Prusiner SB, Kobata A (1989) Diversity of oligosaccharide structures linked to asparagines of the scrapie prion protein. Biochemistry 28:8380–8388PubMedCrossRef Endo T, Groth D, Prusiner SB, Kobata A (1989) Diversity of oligosaccharide structures linked to asparagines of the scrapie prion protein. Biochemistry 28:8380–8388PubMedCrossRef
45.
Zurück zum Zitat Gabizon R, Rosenmann H, Meiner Z et al (1993) Mutation and polymorphism of the prion protein gene in Libyan Jews with Creutzfeldt–Jakob disease. Am J Hum Genet 53:828–835PubMed Gabizon R, Rosenmann H, Meiner Z et al (1993) Mutation and polymorphism of the prion protein gene in Libyan Jews with Creutzfeldt–Jakob disease. Am J Hum Genet 53:828–835PubMed
46.
Zurück zum Zitat Gabizon R, Telling G, Meiner Z, Halimi M, Kahana I, Prusiner SB (1996) Insoluble wild-type and protease-resistant mutant prion protein in brains of patients with inherited prion diseases. Nat Med 2:59–64PubMedCrossRef Gabizon R, Telling G, Meiner Z, Halimi M, Kahana I, Prusiner SB (1996) Insoluble wild-type and protease-resistant mutant prion protein in brains of patients with inherited prion diseases. Nat Med 2:59–64PubMedCrossRef
47.
Zurück zum Zitat Gambetti P, Parchi P, Petersen RB, Chen SG, Lugaresi E (1995) Fatal familial insomnia and familial Creutzfeldt–Jakob disease: clinical, pathological and molecular features. Brain Pathol 5:43–51PubMedCrossRef Gambetti P, Parchi P, Petersen RB, Chen SG, Lugaresi E (1995) Fatal familial insomnia and familial Creutzfeldt–Jakob disease: clinical, pathological and molecular features. Brain Pathol 5:43–51PubMedCrossRef
48.
Zurück zum Zitat Garcin R, Brion S, Khochneviss AA (1963) Le syndrome de Creutzfeldt–Jakob et les syndromes corticotries du presenium (a l’occasion de observations anatomo-cliniques). Rev Neurol (Paris) 109:419–441 Garcin R, Brion S, Khochneviss AA (1963) Le syndrome de Creutzfeldt–Jakob et les syndromes corticotries du presenium (a l’occasion de observations anatomo-cliniques). Rev Neurol (Paris) 109:419–441
49.
Zurück zum Zitat Gelpi E, Kovacs GG, Ströbel T et al (2005) Prion disease with a 144 base pair insertion: unusual cerebellar prion protein immunoreactivity. Acta Neuropathol 110:513–519PubMedCrossRef Gelpi E, Kovacs GG, Ströbel T et al (2005) Prion disease with a 144 base pair insertion: unusual cerebellar prion protein immunoreactivity. Acta Neuropathol 110:513–519PubMedCrossRef
50.
Zurück zum Zitat Goldfarb LG, Mitrová E, Brown P, Toh BK, Gajdusek DC (1990) Mutation in codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt–Jakob disease in Slovakia. Lancet 336:514–515PubMedCrossRef Goldfarb LG, Mitrová E, Brown P, Toh BK, Gajdusek DC (1990) Mutation in codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt–Jakob disease in Slovakia. Lancet 336:514–515PubMedCrossRef
51.
Zurück zum Zitat Goldfarb LG, Brown P, McCombie WR et al (1991) Transmissible familial Creutzfeldt–Jakob disease associated with five, seven and eight extra octapeptide coding repeats in the PRNP gene. Proc Natl Acad Sci USA 88:10926–10930PubMedCrossRef Goldfarb LG, Brown P, McCombie WR et al (1991) Transmissible familial Creutzfeldt–Jakob disease associated with five, seven and eight extra octapeptide coding repeats in the PRNP gene. Proc Natl Acad Sci USA 88:10926–10930PubMedCrossRef
52.
Zurück zum Zitat Goldfarb LG, Brown P, Little BW et al (1993) A new (two-repeat) octapeptide coding insert mutation in Creutzfeldt–Jakob disease. Neurology 43:2392–2394PubMed Goldfarb LG, Brown P, Little BW et al (1993) A new (two-repeat) octapeptide coding insert mutation in Creutzfeldt–Jakob disease. Neurology 43:2392–2394PubMed
53.
Zurück zum Zitat Goldfarb LG, Petersen RB, Tabaton M et al (1992) Fatal familial insomnia and familial Creutzfeldt Jakob disease: disease phenotype determined by a DNA polymorphism. Science 258:806–808PubMedCrossRef Goldfarb LG, Petersen RB, Tabaton M et al (1992) Fatal familial insomnia and familial Creutzfeldt Jakob disease: disease phenotype determined by a DNA polymorphism. Science 258:806–808PubMedCrossRef
54.
Zurück zum Zitat Goldgaber D, Goldfarb LG, Brown P et al (1989) Mutations in familial Creutzfeldt–Jakob disease and Gerstmann-Sträussler-Scheinker’s syndrome. Exp Neurol 106:204–206PubMedCrossRef Goldgaber D, Goldfarb LG, Brown P et al (1989) Mutations in familial Creutzfeldt–Jakob disease and Gerstmann-Sträussler-Scheinker’s syndrome. Exp Neurol 106:204–206PubMedCrossRef
55.
Zurück zum Zitat Grasbon-Frodl E, Lorenz H, Mann U, Nitsch RM, Windl O, Kretzschmar HA (2004) Loss of glycosylation associated with the T183A mutation in human prion disease. Acta Neuropathol 108:476–484PubMedCrossRef Grasbon-Frodl E, Lorenz H, Mann U, Nitsch RM, Windl O, Kretzschmar HA (2004) Loss of glycosylation associated with the T183A mutation in human prion disease. Acta Neuropathol 108:476–484PubMedCrossRef
56.
Zurück zum Zitat Hama T, Iwasaki Y, Niwa H et al (2009) An autopsied case of panencephalopathic-type Creutzfeldt–Jakob disease with mutation in the prion protein gene at codon 232 and type 1 prion protein. Neuropathology 296:727–734CrossRef Hama T, Iwasaki Y, Niwa H et al (2009) An autopsied case of panencephalopathic-type Creutzfeldt–Jakob disease with mutation in the prion protein gene at codon 232 and type 1 prion protein. Neuropathology 296:727–734CrossRef
57.
Zurück zum Zitat Hainfellner JA, Parchi P, Kitamoto T, Jarius C, Gambetti P, Budka H (1999) A novel phenotype in familial Creutzfeldt–Jakob disease: prion protein gene E200K mutation coupled with valine at codon 129 and type 2 protease-resistant prion protein. Ann Neurol 45:812–816PubMedCrossRef Hainfellner JA, Parchi P, Kitamoto T, Jarius C, Gambetti P, Budka H (1999) A novel phenotype in familial Creutzfeldt–Jakob disease: prion protein gene E200K mutation coupled with valine at codon 129 and type 2 protease-resistant prion protein. Ann Neurol 45:812–816PubMedCrossRef
58.
Zurück zum Zitat Hill AF, Joiner S, Beck JA et al (2006) Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations. Brain 129:676–685PubMedCrossRef Hill AF, Joiner S, Beck JA et al (2006) Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations. Brain 129:676–685PubMedCrossRef
59.
Zurück zum Zitat Hsiao KK, Scott M, Foster D, Groth DF, DeArmond SJ, Prusiner SB (1990) Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 250:1587–1590PubMedCrossRef Hsiao KK, Scott M, Foster D, Groth DF, DeArmond SJ, Prusiner SB (1990) Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 250:1587–1590PubMedCrossRef
60.
Zurück zum Zitat Hsiao KK, Groth D, Scott M et al (1994) Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc Natl Acad Sci USA 91:9126–9130PubMedCrossRef Hsiao KK, Groth D, Scott M et al (1994) Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc Natl Acad Sci USA 91:9126–9130PubMedCrossRef
61.
Zurück zum Zitat Huang Z, Gabriel JM, Baldwin MA, Fletterick RJ, Prusiner SB, Cohen FE (1994) Proposed three-dimensional structure for the cellular prion protein. Proc Natl Acad Sci USA 91:7139–7143PubMedCrossRef Huang Z, Gabriel JM, Baldwin MA, Fletterick RJ, Prusiner SB, Cohen FE (1994) Proposed three-dimensional structure for the cellular prion protein. Proc Natl Acad Sci USA 91:7139–7143PubMedCrossRef
62.
Zurück zum Zitat Ivanova L, Barmada S, Kummer T, Harris DA (2001) Mutant prion proteins are partially retained in the endoplasmic reticulum. J Biol Chem 276:42409–42421PubMedCrossRef Ivanova L, Barmada S, Kummer T, Harris DA (2001) Mutant prion proteins are partially retained in the endoplasmic reticulum. J Biol Chem 276:42409–42421PubMedCrossRef
63.
Zurück zum Zitat Jackson WS, Borkowski AW, Faas H et al (2009) Spontaneous generation of prion infectivity in fatal familial insomnia knocking mice. Neuron 63:438–450PubMedCrossRef Jackson WS, Borkowski AW, Faas H et al (2009) Spontaneous generation of prion infectivity in fatal familial insomnia knocking mice. Neuron 63:438–450PubMedCrossRef
64.
Zurück zum Zitat Jacob H, Pyrkosch W, Strube H (1950) The hereditary form of Creutzfeldt–Jakob disease (the Backer family). Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr 184:653–674PubMed Jacob H, Pyrkosch W, Strube H (1950) The hereditary form of Creutzfeldt–Jakob disease (the Backer family). Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr 184:653–674PubMed
65.
Zurück zum Zitat Jansen C, van Swieten JC, Capellari S et al (2009) Inherited Creutzfeldt–Jakob disease in a Dutch patient with a novel five octapeptide repeat insertion and unusual cerebellar morphology. J Neurol Neurosurg Psychiatry 80:1386–1389PubMedCrossRef Jansen C, van Swieten JC, Capellari S et al (2009) Inherited Creutzfeldt–Jakob disease in a Dutch patient with a novel five octapeptide repeat insertion and unusual cerebellar morphology. J Neurol Neurosurg Psychiatry 80:1386–1389PubMedCrossRef
66.
Zurück zum Zitat Jarius C, Kovacs GG, Belay G, Hainfellner JA, Mitrova E, Budka H (2003) Distinctive cerebellar immunoreactivity for the prion protein in familial (E200K) Creutzfeldt–Jakob disease. Acta Neuropathol 105:49–54 Jarius C, Kovacs GG, Belay G, Hainfellner JA, Mitrova E, Budka H (2003) Distinctive cerebellar immunoreactivity for the prion protein in familial (E200K) Creutzfeldt–Jakob disease. Acta Neuropathol 105:49–54
67.
Zurück zum Zitat Jin K, Shiga Y, Shibuya S et al (2004) Clinical features of Creutzfeldt–Jakob disease with V180I mutation. Neurology 62:502–505PubMed Jin K, Shiga Y, Shibuya S et al (2004) Clinical features of Creutzfeldt–Jakob disease with V180I mutation. Neurology 62:502–505PubMed
68.
Zurück zum Zitat Kahana E, Zilber N, Abraham M (1991) Do Creutzfeldt–Jakob disease patients of Jewish Libyan origin have unique clinical features? Neurology 41:1390–1392PubMed Kahana E, Zilber N, Abraham M (1991) Do Creutzfeldt–Jakob disease patients of Jewish Libyan origin have unique clinical features? Neurology 41:1390–1392PubMed
69.
Zurück zum Zitat Kalastavadi T, True HL (2008) Prion protein insertional mutations increase aggregation propensity but not fiber stability. BMC Biochem 9:7PubMedCrossRef Kalastavadi T, True HL (2008) Prion protein insertional mutations increase aggregation propensity but not fiber stability. BMC Biochem 9:7PubMedCrossRef
70.
Zurück zum Zitat Kascsak RJ, Rubenstein R, Merz PA et al (1986) Immunological comparison of scrapie-associated fibrils isolated from animals infected with four different scrapie strains. J Virol 59:676–683PubMed Kascsak RJ, Rubenstein R, Merz PA et al (1986) Immunological comparison of scrapie-associated fibrils isolated from animals infected with four different scrapie strains. J Virol 59:676–683PubMed
71.
Zurück zum Zitat Kiachopoulos S, Bracher A, Winklhofer KF, Tatzelt J (2005) Pathogenic mutations located in the hydrophobic core of the prion protein interfere with folding and attachment of the glycosylphosphatidylinositol anchor. J Biol Chem 280:9320–9329PubMedCrossRef Kiachopoulos S, Bracher A, Winklhofer KF, Tatzelt J (2005) Pathogenic mutations located in the hydrophobic core of the prion protein interfere with folding and attachment of the glycosylphosphatidylinositol anchor. J Biol Chem 280:9320–9329PubMedCrossRef
72.
Zurück zum Zitat Kirschbaum WR (1924) Zwei eigenartige Erkrankung des Zentralnervensystems nach Art der spatischen Pseudosklerose (Jakob). Z Neurol Pyschiatry 92:175–220CrossRef Kirschbaum WR (1924) Zwei eigenartige Erkrankung des Zentralnervensystems nach Art der spatischen Pseudosklerose (Jakob). Z Neurol Pyschiatry 92:175–220CrossRef
73.
Zurück zum Zitat Kobayashi A, Sakuma N, Matsuura Y, Mohri S, Aguzzi A, Kitamoto T (2010) Experimental verification of a traceback phenomenon in prion infection. J Virol 84:3230–3238PubMedCrossRef Kobayashi A, Sakuma N, Matsuura Y, Mohri S, Aguzzi A, Kitamoto T (2010) Experimental verification of a traceback phenomenon in prion infection. J Virol 84:3230–3238PubMedCrossRef
74.
Zurück zum Zitat Kong Q, Surewicz WK, Petersen RB et al (2003) Inherited prion diseases. In: Prusiner SB (ed) Prion biology disease. Cold Spring Harbor Laboratory Press, New York, pp 673–775 Kong Q, Surewicz WK, Petersen RB et al (2003) Inherited prion diseases. In: Prusiner SB (ed) Prion biology disease. Cold Spring Harbor Laboratory Press, New York, pp 673–775
75.
Zurück zum Zitat Kovács GG, Trabattoni G, Hainfellner JA, Ironside JW, Knight RS, Budka H (2002) Mutations of the prion protein gene phenotypic spectrum. J Neurol 249:1567–1582PubMedCrossRef Kovács GG, Trabattoni G, Hainfellner JA, Ironside JW, Knight RS, Budka H (2002) Mutations of the prion protein gene phenotypic spectrum. J Neurol 249:1567–1582PubMedCrossRef
76.
Zurück zum Zitat Kovács GG, Puopolo M, Ladogana A et al (2005) Genetic prion disease: the EUROCJD experience. Hum Genet 118:166–174PubMedCrossRef Kovács GG, Puopolo M, Ladogana A et al (2005) Genetic prion disease: the EUROCJD experience. Hum Genet 118:166–174PubMedCrossRef
77.
Zurück zum Zitat Krasnianski A, Bartl M, Sanchez Juan PJ et al (2008) Fatal familial insomnia: clinical features and early identification. Ann Neurol 63:658–661PubMedCrossRef Krasnianski A, Bartl M, Sanchez Juan PJ et al (2008) Fatal familial insomnia: clinical features and early identification. Ann Neurol 63:658–661PubMedCrossRef
78.
Zurück zum Zitat Krebs B, Lederer RM, Windl O, Grasbon-Frodl EM, Zerr I, Kretzschmar HA (2005) Creutzfeldt–Jakob disease associated with an R148H mutation of the prion protein gene. Neurogenetics 6:97–100PubMedCrossRef Krebs B, Lederer RM, Windl O, Grasbon-Frodl EM, Zerr I, Kretzschmar HA (2005) Creutzfeldt–Jakob disease associated with an R148H mutation of the prion protein gene. Neurogenetics 6:97–100PubMedCrossRef
79.
Zurück zum Zitat Kretzschmar HA, Stowring LE, Westaway D, Stubblebine WH, Prusiner SB, Dearmond SJ (1986) Molecular cloning of a human prion protein cDNA. DNA 5:315–324PubMed Kretzschmar HA, Stowring LE, Westaway D, Stubblebine WH, Prusiner SB, Dearmond SJ (1986) Molecular cloning of a human prion protein cDNA. DNA 5:315–324PubMed
80.
Zurück zum Zitat Kretzschmar HA, Neumann M, Stavrou D (1995) Codon 178 mutation of the human prion protein gene in a German family (Backer family): sequencing data from 72-year old celloidin-embedded brain tissue. Acta Neuropathol 89:96–98PubMedCrossRef Kretzschmar HA, Neumann M, Stavrou D (1995) Codon 178 mutation of the human prion protein gene in a German family (Backer family): sequencing data from 72-year old celloidin-embedded brain tissue. Acta Neuropathol 89:96–98PubMedCrossRef
81.
Zurück zum Zitat Ladogana A, Almonti S, Petraroli R et al (2001) Mutation of the PRNP gene at codon 211 in familial Creutzfeldt–Jakob disease. Am J Med Genet 103:133–137PubMedCrossRef Ladogana A, Almonti S, Petraroli R et al (2001) Mutation of the PRNP gene at codon 211 in familial Creutzfeldt–Jakob disease. Am J Med Genet 103:133–137PubMedCrossRef
82.
Zurück zum Zitat Ladogana A, Puopolo M, Poleggi A et al (2005) High incidence of genetic human transmissible spongiform encephalopathies in Italy. Neurology 64:1592–1597PubMedCrossRef Ladogana A, Puopolo M, Poleggi A et al (2005) High incidence of genetic human transmissible spongiform encephalopathies in Italy. Neurology 64:1592–1597PubMedCrossRef
83.
Zurück zum Zitat Langella E, Improta R, Crescenzi O, Barone V (2006) Assessing the acid-base and conformational properties of histidine residues in human prion protein (125–228) by means of pK(a) calculations and molecular dynamics simulations. Proteins 64:167–177PubMedCrossRef Langella E, Improta R, Crescenzi O, Barone V (2006) Assessing the acid-base and conformational properties of histidine residues in human prion protein (125–228) by means of pK(a) calculations and molecular dynamics simulations. Proteins 64:167–177PubMedCrossRef
84.
Zurück zum Zitat Laplanche JL, Delasnerie-Laupretre N, Brandel JP et al (1994) Molecular genetics of prion diseases in France. Neurology 44:2347–2351PubMed Laplanche JL, Delasnerie-Laupretre N, Brandel JP et al (1994) Molecular genetics of prion diseases in France. Neurology 44:2347–2351PubMed
85.
Zurück zum Zitat Lehmann S, Harris DA (1996) Mutant and infectious prion proteins display common biochemical properties in cultured cells. J Biol Chem 271:1633–1637PubMedCrossRef Lehmann S, Harris DA (1996) Mutant and infectious prion proteins display common biochemical properties in cultured cells. J Biol Chem 271:1633–1637PubMedCrossRef
86.
Zurück zum Zitat Lehmann S, Harris DA (1996) Two mutant prion proteins expressed in cultured cells acquire biochemical properties reminiscent of the scrapie isoform. Proc Natl Acad Sci 93:5610–5614PubMedCrossRef Lehmann S, Harris DA (1996) Two mutant prion proteins expressed in cultured cells acquire biochemical properties reminiscent of the scrapie isoform. Proc Natl Acad Sci 93:5610–5614PubMedCrossRef
87.
Zurück zum Zitat Leliveld SR, Stitz L, Korth C (2008) Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein. Biochemistry 47:6267–6278PubMedCrossRef Leliveld SR, Stitz L, Korth C (2008) Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein. Biochemistry 47:6267–6278PubMedCrossRef
88.
Zurück zum Zitat Lewis PA, Tattum MH, Jones S et al (2006) Codon 129 polymorphism of the human prion protein influences the kinetics of amyloid formation. J Gen Virol 87:2443–2449PubMedCrossRef Lewis PA, Tattum MH, Jones S et al (2006) Codon 129 polymorphism of the human prion protein influences the kinetics of amyloid formation. J Gen Virol 87:2443–2449PubMedCrossRef
89.
Zurück zum Zitat Liemann S, Glockshuber R (1999) Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. Biochemistry 38:3258–3267PubMedCrossRef Liemann S, Glockshuber R (1999) Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. Biochemistry 38:3258–3267PubMedCrossRef
90.
Zurück zum Zitat Little BW, Brown PW, Rodgers-Johnson P, Perl DP, Gajdusek DC (1986) Familial myoclonic dementia masquerading as Creutzfeldt–Jakob disease. Ann Neurol 20:231–239PubMedCrossRef Little BW, Brown PW, Rodgers-Johnson P, Perl DP, Gajdusek DC (1986) Familial myoclonic dementia masquerading as Creutzfeldt–Jakob disease. Ann Neurol 20:231–239PubMedCrossRef
91.
Zurück zum Zitat Liu Z, Jia L, Piao Y et al. (2009) Creutzfeldt–Jakob disease with PRNP G114V mutation in a Chinese family. Acta Neurol Scand (epub ahead of print) Liu Z, Jia L, Piao Y et al. (2009) Creutzfeldt–Jakob disease with PRNP G114V mutation in a Chinese family. Acta Neurol Scand (epub ahead of print)
92.
Zurück zum Zitat Lorenz H, Windl O, Kretzschmar HA (2002) Cellular phenotyping of secretory and nuclear prion proteins associated with inherited prion diseases. J Biol Chem 277:8508–8516PubMedCrossRef Lorenz H, Windl O, Kretzschmar HA (2002) Cellular phenotyping of secretory and nuclear prion proteins associated with inherited prion diseases. J Biol Chem 277:8508–8516PubMedCrossRef
93.
Zurück zum Zitat Lugaresi E, Medori R, Montagna P et al (1986) Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med 315:997–1003PubMedCrossRef Lugaresi E, Medori R, Montagna P et al (1986) Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med 315:997–1003PubMedCrossRef
94.
Zurück zum Zitat Ma J, Lindquist S (2001) Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation. Proc Natl Acad Sci 98:14955–14960PubMedCrossRef Ma J, Lindquist S (2001) Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation. Proc Natl Acad Sci 98:14955–14960PubMedCrossRef
95.
Zurück zum Zitat Manetto V, Medori R, Cortelli P et al (1992) Fatal familial insomnia: clinical and pathologic study of five new cases. Neurology 42:312–319PubMed Manetto V, Medori R, Cortelli P et al (1992) Fatal familial insomnia: clinical and pathologic study of five new cases. Neurology 42:312–319PubMed
96.
Zurück zum Zitat Manson JC, Jamieson E, Baybutt H et al (1999) A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy. EMBO J 18:6855–6864PubMedCrossRef Manson JC, Jamieson E, Baybutt H et al (1999) A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy. EMBO J 18:6855–6864PubMedCrossRef
97.
Zurück zum Zitat Martin JJ, Yap M, Nei IP, Tan TE (1983) Selective thalamic degeneration: report of a case with memory and mental disturbances. Clin Neuropathol 2:156–162PubMed Martin JJ, Yap M, Nei IP, Tan TE (1983) Selective thalamic degeneration: report of a case with memory and mental disturbances. Clin Neuropathol 2:156–162PubMed
98.
Zurück zum Zitat Massignan T, Biasini E, Lauranzano E et al (2010) Mutant prion protein expression is associated with an alteration of the Rab GDP dissociation inhibitor alpha (GDI)/Rab11 pathway. Mol Cell Proteomics 9:611–622PubMedCrossRef Massignan T, Biasini E, Lauranzano E et al (2010) Mutant prion protein expression is associated with an alteration of the Rab GDP dissociation inhibitor alpha (GDI)/Rab11 pathway. Mol Cell Proteomics 9:611–622PubMedCrossRef
99.
Zurück zum Zitat Mastrianni JA, Iannicola C, Myers RM, DeArmond S, Prusiner SB (1996) Mutation of the prion protein gene at codon 208 in familial Creutzfeldt–Jakob disease. Neurology 47:1305–1312PubMed Mastrianni JA, Iannicola C, Myers RM, DeArmond S, Prusiner SB (1996) Mutation of the prion protein gene at codon 208 in familial Creutzfeldt–Jakob disease. Neurology 47:1305–1312PubMed
100.
Zurück zum Zitat Mastrianni J, Nixon R, Layzer R et al (1999) Prion protein conformation in a patient with sporadic fatal insomnia. N Engl J Med 340:1630–1638PubMedCrossRef Mastrianni J, Nixon R, Layzer R et al (1999) Prion protein conformation in a patient with sporadic fatal insomnia. N Engl J Med 340:1630–1638PubMedCrossRef
101.
Zurück zum Zitat Mastrianni JA, Capellari S, Telling GC et al (2001) Inherited prion disease caused by the V210I mutation: transmission to transgenic mice. Neurology 57:2198–2205PubMed Mastrianni JA, Capellari S, Telling GC et al (2001) Inherited prion disease caused by the V210I mutation: transmission to transgenic mice. Neurology 57:2198–2205PubMed
102.
Zurück zum Zitat Mead S, Poulter M, Beck J et al (2006) Inherited prion disease with six octapeptide repeat insertional mutation-molecular analysis of phenotypic heterogeneity. Brain 129:2297–2317PubMedCrossRef Mead S, Poulter M, Beck J et al (2006) Inherited prion disease with six octapeptide repeat insertional mutation-molecular analysis of phenotypic heterogeneity. Brain 129:2297–2317PubMedCrossRef
103.
Zurück zum Zitat Mead S, Webb TEF, Campbell TA et al (2007) Inherited prion disease with 5-OPRI. Neurology 69:730–738PubMedCrossRef Mead S, Webb TEF, Campbell TA et al (2007) Inherited prion disease with 5-OPRI. Neurology 69:730–738PubMedCrossRef
104.
Zurück zum Zitat Medori R, Tritschler HJ, LeBlanc A et al (1992) Fatal familial insomnia is a prion disease with a mutation at codon 178 of the prion gene. N Engl J Med 326:444–449PubMedCrossRef Medori R, Tritschler HJ, LeBlanc A et al (1992) Fatal familial insomnia is a prion disease with a mutation at codon 178 of the prion gene. N Engl J Med 326:444–449PubMedCrossRef
105.
Zurück zum Zitat Meggendorfer F (1930) Klinische und genealogische Beobachtungen bein einem Fall von spastischen Pseudokosklerose Jakobs. Z Neurol Psychiatry 128:337–341CrossRef Meggendorfer F (1930) Klinische und genealogische Beobachtungen bein einem Fall von spastischen Pseudokosklerose Jakobs. Z Neurol Psychiatry 128:337–341CrossRef
106.
Zurück zum Zitat Mitrova E, Belay G (2002) Creutzfeldt–Jakob disease with E200K mutation in Slovakia: characterization and development. Acta Virol 46:31–39PubMed Mitrova E, Belay G (2002) Creutzfeldt–Jakob disease with E200K mutation in Slovakia: characterization and development. Acta Virol 46:31–39PubMed
107.
Zurück zum Zitat Miyakawa T, Inoue K, Iseki E et al (1998) Japanese Creutzfeldt–Jakob disease patients exhibiting high incidence of the E200K PRNP mutation and located in the basin of a river. Neurol Res 20:684–688PubMed Miyakawa T, Inoue K, Iseki E et al (1998) Japanese Creutzfeldt–Jakob disease patients exhibiting high incidence of the E200K PRNP mutation and located in the basin of a river. Neurol Res 20:684–688PubMed
108.
Zurück zum Zitat Monari L, Chen SC, Brown P et al (1994) Fatal familial insomnia and familial Creutzfeldt–Jakob disease: different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci USA 91:2839–2842PubMedCrossRef Monari L, Chen SC, Brown P et al (1994) Fatal familial insomnia and familial Creutzfeldt–Jakob disease: different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci USA 91:2839–2842PubMedCrossRef
109.
Zurück zum Zitat Montagna P, Gambetti P, Cortelli P, Lugaresi E (2003) Familial and sporadic fatal insomnia. Lancet Neurol 2:167–176PubMedCrossRef Montagna P, Gambetti P, Cortelli P, Lugaresi E (2003) Familial and sporadic fatal insomnia. Lancet Neurol 2:167–176PubMedCrossRef
110.
Zurück zum Zitat Neufeld MY, Josiphov J, Korczyn AD (1992) Demyelinating peripheral neuropathy in Creutzfeldt–Jakob disease. Muscle Nerve 15:1234–1239PubMedCrossRef Neufeld MY, Josiphov J, Korczyn AD (1992) Demyelinating peripheral neuropathy in Creutzfeldt–Jakob disease. Muscle Nerve 15:1234–1239PubMedCrossRef
111.
Zurück zum Zitat Nicolas O, Gavín R, del Río JA (2009) New insights into cellular prion protein (PrPc) functions: the “ying and yang” of a relevant protein. Brain Res Rev 61:170–184PubMedCrossRef Nicolas O, Gavín R, del Río JA (2009) New insights into cellular prion protein (PrPc) functions: the “ying and yang” of a relevant protein. Brain Res Rev 61:170–184PubMedCrossRef
112.
Zurück zum Zitat Nitrini R, Rosemberg S, Passos-Bueno MR et al (1997) Familial spongiform encephalopathy with distinct clinico-pathological features associated with a novel prion gene mutation at codon 183. Ann Neurol 42:138–146PubMedCrossRef Nitrini R, Rosemberg S, Passos-Bueno MR et al (1997) Familial spongiform encephalopathy with distinct clinico-pathological features associated with a novel prion gene mutation at codon 183. Ann Neurol 42:138–146PubMedCrossRef
113.
Zurück zum Zitat Nonno R, Di Bari M, Cardone F et al (2006) Efficient transmission and characterization of Creutzfeldt–Jakob disease strains in bank voles. PLoS Pathog 2:e12PubMedCrossRef Nonno R, Di Bari M, Cardone F et al (2006) Efficient transmission and characterization of Creutzfeldt–Jakob disease strains in bank voles. PLoS Pathog 2:e12PubMedCrossRef
114.
Zurück zum Zitat Notari S, Capellari S, Giese A et al (2004) Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD. J Biol Chem 279:16797–16804PubMedCrossRef Notari S, Capellari S, Giese A et al (2004) Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD. J Biol Chem 279:16797–16804PubMedCrossRef
115.
Zurück zum Zitat Notari S, Strammiello R, Capellari S et al (2008) Characterization of truncated forms of abnormal prion protein in Creutzfeldt–Jakob disease. J Biol Chem 283:30557–30565PubMedCrossRef Notari S, Strammiello R, Capellari S et al (2008) Characterization of truncated forms of abnormal prion protein in Creutzfeldt–Jakob disease. J Biol Chem 283:30557–30565PubMedCrossRef
116.
Zurück zum Zitat Oda M (1976) Thalamus degeneration in Japan: a review from clinical and pathological veiwpoints. Appl Neurophysiol 39:178–198PubMed Oda M (1976) Thalamus degeneration in Japan: a review from clinical and pathological veiwpoints. Appl Neurophysiol 39:178–198PubMed
117.
Zurück zum Zitat Owen F, Poulter M, Lofthouse R et al (1989) Insertion in prion protein gene in familial Creutzfeldt–Jakob disease. Lancet 7:51–52CrossRef Owen F, Poulter M, Lofthouse R et al (1989) Insertion in prion protein gene in familial Creutzfeldt–Jakob disease. Lancet 7:51–52CrossRef
118.
Zurück zum Zitat Palmer MS, Dryden AJ, Hughes JT, Collinge J (1991) Homozygous prion protein genotype predisposes to sporadic Creutzfeldt–Jakob disease. Nature 352:340–342PubMedCrossRef Palmer MS, Dryden AJ, Hughes JT, Collinge J (1991) Homozygous prion protein genotype predisposes to sporadic Creutzfeldt–Jakob disease. Nature 352:340–342PubMedCrossRef
119.
Zurück zum Zitat Parchi P, Castellani R, Cortelli P et al (1995) Regional distribution of protease-resistant prion protein in fatal familial insomnia. Ann Neurol 38:21–29PubMedCrossRef Parchi P, Castellani R, Cortelli P et al (1995) Regional distribution of protease-resistant prion protein in fatal familial insomnia. Ann Neurol 38:21–29PubMedCrossRef
120.
Zurück zum Zitat Parchi P, Castellani R, Capellari S et al (1996) Molecular basis of phenotypic variability in sporadic Creutzfeldt–Jakob disease. Ann Neurol 39:767–778PubMedCrossRef Parchi P, Castellani R, Capellari S et al (1996) Molecular basis of phenotypic variability in sporadic Creutzfeldt–Jakob disease. Ann Neurol 39:767–778PubMedCrossRef
121.
122.
Zurück zum Zitat Parchi P, Petersen RB, Chen SG et al (1998) Molecular pathology of fatal familial insomnia. Brain Pathol 8:539–548PubMedCrossRef Parchi P, Petersen RB, Chen SG et al (1998) Molecular pathology of fatal familial insomnia. Brain Pathol 8:539–548PubMedCrossRef
123.
Zurück zum Zitat Parchi P, Giese A, Capellari S et al (1999) Classification of sporadic Creutzfeldt–Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46:224–233PubMedCrossRef Parchi P, Giese A, Capellari S et al (1999) Classification of sporadic Creutzfeldt–Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46:224–233PubMedCrossRef
124.
Zurück zum Zitat Parchi P, Capellari S, Chin S et al (1999) A sporadic prion disease mimicking fatal familial insomnia. Neurology 52:1757–1763PubMed Parchi P, Capellari S, Chin S et al (1999) A sporadic prion disease mimicking fatal familial insomnia. Neurology 52:1757–1763PubMed
125.
Zurück zum Zitat Parchi P, Zou W, Wang W et al (2000) Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci USA 97:10168–10171PubMedCrossRef Parchi P, Zou W, Wang W et al (2000) Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci USA 97:10168–10171PubMedCrossRef
126.
Zurück zum Zitat Parchi P, Strammiello R, Notari S et al (2009) Incidence and spectrum of sporadic Creutzfeldt–Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification. Acta Neuropathol 118:659–671PubMedCrossRef Parchi P, Strammiello R, Notari S et al (2009) Incidence and spectrum of sporadic Creutzfeldt–Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification. Acta Neuropathol 118:659–671PubMedCrossRef
127.
Zurück zum Zitat Parchi P, Notari S, Weber P et al (2009) Inter-laboratory assessment of PrPSc typing in Creutzfeldt–Jakob disease: a western blot study within the NeuroPrion Consortium. Brain Pathol 19:384–391PubMedCrossRef Parchi P, Notari S, Weber P et al (2009) Inter-laboratory assessment of PrPSc typing in Creutzfeldt–Jakob disease: a western blot study within the NeuroPrion Consortium. Brain Pathol 19:384–391PubMedCrossRef
128.
Zurück zum Zitat Parchi P, Cescatti M, Notari S et al. (2010) Agent strain variation in human prion disease: insights from a molecular and pathological revision of the NIH series of experimentally transmitted disease. Brain 133:3030–3042 Parchi P, Cescatti M, Notari S et al. (2010) Agent strain variation in human prion disease: insights from a molecular and pathological revision of the NIH series of experimentally transmitted disease. Brain 133:3030–3042
129.
Zurück zum Zitat Pastore M, Chin SS, Bell KL et al (2005) Creutzfeldt–Jakob disease (CJD) with a mutation at codon 148 of prion protein gene: relationship with sporadic CJD. Am J Pathol 167:1729–1738PubMed Pastore M, Chin SS, Bell KL et al (2005) Creutzfeldt–Jakob disease (CJD) with a mutation at codon 148 of prion protein gene: relationship with sporadic CJD. Am J Pathol 167:1729–1738PubMed
130.
Zurück zum Zitat Peoc’h K, Manivet P, Beaudry P et al (2000) Identification of three novel mutations (E196K, V203I, E211Q) in the prion protein gene (PRNP) in inherited prion diseases with Creutzfeldt–Jakob disease phenotype. Hum Mutat 5:482CrossRef Peoc’h K, Manivet P, Beaudry P et al (2000) Identification of three novel mutations (E196K, V203I, E211Q) in the prion protein gene (PRNP) in inherited prion diseases with Creutzfeldt–Jakob disease phenotype. Hum Mutat 5:482CrossRef
131.
Zurück zum Zitat Petersen RB, Tabaton M, Berg L et al (1992) Analysis of the prion gene in thalamic dementia. Neurology 42:1859–1863PubMed Petersen RB, Tabaton M, Berg L et al (1992) Analysis of the prion gene in thalamic dementia. Neurology 42:1859–1863PubMed
132.
Zurück zum Zitat Petersen RB, Parchi P, Richardson SL, Urig CB, Gambetti P (1996) Effect of the D178N mutation and the codon 129 polymorphism on the metabolism of the prion protein. J Biol Chem 271:12661–12668PubMedCrossRef Petersen RB, Parchi P, Richardson SL, Urig CB, Gambetti P (1996) Effect of the D178N mutation and the codon 129 polymorphism on the metabolism of the prion protein. J Biol Chem 271:12661–12668PubMedCrossRef
133.
Zurück zum Zitat Pocchiari M, Salvatore M, Cutruzzola F et al (1993) A new point mutation of the prion protein gene in Creutzfeldt–Jakob disease. Ann Neurol 34:802–807PubMedCrossRef Pocchiari M, Salvatore M, Cutruzzola F et al (1993) A new point mutation of the prion protein gene in Creutzfeldt–Jakob disease. Ann Neurol 34:802–807PubMedCrossRef
134.
Zurück zum Zitat Priola SA, Chesebro B (1998) Abnormal properties of prion protein with insertional mutations in different cell types. J Biol Chem 273:11980–11985PubMedCrossRef Priola SA, Chesebro B (1998) Abnormal properties of prion protein with insertional mutations in different cell types. J Biol Chem 273:11980–11985PubMedCrossRef
136.
Zurück zum Zitat Puckett C, Concannon P, Casey C, Hood L (1991) Genomic structure of human prion protein gene. Am J Genet 49:320–329 Puckett C, Concannon P, Casey C, Hood L (1991) Genomic structure of human prion protein gene. Am J Genet 49:320–329
137.
Zurück zum Zitat Puoti G, Rossi G, Giaccone G et al (2000) Polymorphism at codon 129 of PRNP affects the phenotypic expression of Creutzfeldt–Jakob disease linked to the E200K mutation. Ann Neurol 48:269–270PubMedCrossRef Puoti G, Rossi G, Giaccone G et al (2000) Polymorphism at codon 129 of PRNP affects the phenotypic expression of Creutzfeldt–Jakob disease linked to the E200K mutation. Ann Neurol 48:269–270PubMedCrossRef
138.
Zurück zum Zitat Riek R, Wider G, Billeter M, Hornemann S, Glockshuber R, Wüthrich K (1998) Prion protein NMR structure and familial human spongiform encephalopathies. Proc Natl Acad Sci 95:11667–11672PubMedCrossRef Riek R, Wider G, Billeter M, Hornemann S, Glockshuber R, Wüthrich K (1998) Prion protein NMR structure and familial human spongiform encephalopathies. Proc Natl Acad Sci 95:11667–11672PubMedCrossRef
139.
Zurück zum Zitat Ripoll L, Laplanche JL, Salzmann M et al (1993) A new point mutation in the prion protein gene at codon 210 in Creutzfeldt–Jakob disease. Neurology 43:1934–1938PubMed Ripoll L, Laplanche JL, Salzmann M et al (1993) A new point mutation in the prion protein gene at codon 210 in Creutzfeldt–Jakob disease. Neurology 43:1934–1938PubMed
140.
Zurück zum Zitat Rodriguez MM, Peoc’h K, Haïk S et al (2005) A novel mutation (G114V) in the prion protein gene in a family with inherited prion disease. Neurology 64:1455–1457PubMed Rodriguez MM, Peoc’h K, Haïk S et al (2005) A novel mutation (G114V) in the prion protein gene in a family with inherited prion disease. Neurology 64:1455–1457PubMed
141.
Zurück zum Zitat Rodríguez-Martínez AB, Barreau C, Coupry I et al (2005) Ancestral origins of the prion protein gene D178N mutation in the Basque Country. Hum Genet 117:61–69PubMedCrossRef Rodríguez-Martínez AB, Barreau C, Coupry I et al (2005) Ancestral origins of the prion protein gene D178N mutation in the Basque Country. Hum Genet 117:61–69PubMedCrossRef
142.
Zurück zum Zitat Roeber S, Krebs B, Neumann M et al (2005) Creutzfeldt–Jakob disease in a patient with an R208H mutation of the prion protein gene (PRNP) and a 17-kDa prion protein fragment. Acta Neuropathol 109:443–448PubMedCrossRef Roeber S, Krebs B, Neumann M et al (2005) Creutzfeldt–Jakob disease in a patient with an R208H mutation of the prion protein gene (PRNP) and a 17-kDa prion protein fragment. Acta Neuropathol 109:443–448PubMedCrossRef
143.
Zurück zum Zitat Roeber S, Grasbon-Frodl EM, Windl O et al (2008) Evidence for a pathogenic role of different mutations at codon 188 of PRNP. PLoS One 3:e2147PubMedCrossRef Roeber S, Grasbon-Frodl EM, Windl O et al (2008) Evidence for a pathogenic role of different mutations at codon 188 of PRNP. PLoS One 3:e2147PubMedCrossRef
144.
Zurück zum Zitat Rogers M, Taraboulos A, Scott M, Groth D, Prusiner SB (1990) Intracellular accumulation of the cellular prion protein after mutagenesis of its Asn-linked glycosylation sites. Glycobiology 1:101–109PubMedCrossRef Rogers M, Taraboulos A, Scott M, Groth D, Prusiner SB (1990) Intracellular accumulation of the cellular prion protein after mutagenesis of its Asn-linked glycosylation sites. Glycobiology 1:101–109PubMedCrossRef
145.
Zurück zum Zitat Roos R, Gajdusek DC, Gibbs CJ (1973) The clinical characteristics of transmissible Creutzfeldt–Jacob disease. Brain 96:1–20PubMedCrossRef Roos R, Gajdusek DC, Gibbs CJ (1973) The clinical characteristics of transmissible Creutzfeldt–Jacob disease. Brain 96:1–20PubMedCrossRef
146.
Zurück zum Zitat Rosenmann H, Talmor G, Halimi M, Yanai A, Gabizon R, Meiner Z (2001) Prion protein with an E200K mutation displays properties similar to those of the cellular isoform PrP(C). J Neurochem 76:1654–1662PubMedCrossRef Rosenmann H, Talmor G, Halimi M, Yanai A, Gabizon R, Meiner Z (2001) Prion protein with an E200K mutation displays properties similar to those of the cellular isoform PrP(C). J Neurochem 76:1654–1662PubMedCrossRef
147.
Zurück zum Zitat Schiff E, Campana V, Tivodar S, Lebreton S, Gousset K, Zurzolo C (2008) Coexpression of wild-type and mutant prion proteins alters their cellular localization and partitioning into detergent-resistant membranes. Traffic 9:1101–1115PubMedCrossRef Schiff E, Campana V, Tivodar S, Lebreton S, Gousset K, Zurzolo C (2008) Coexpression of wild-type and mutant prion proteins alters their cellular localization and partitioning into detergent-resistant membranes. Traffic 9:1101–1115PubMedCrossRef
148.
Zurück zum Zitat Schulman S (1957) Bilateral symmetrical degeneration of the thalamus: a clinico-pathological study. J Neuropathol Exp Neurol 16:446–470PubMedCrossRef Schulman S (1957) Bilateral symmetrical degeneration of the thalamus: a clinico-pathological study. J Neuropathol Exp Neurol 16:446–470PubMedCrossRef
149.
Zurück zum Zitat Shimizu H, Yamada M, Matsubara N et al (2009) Creutzfeldt–Jakob disease with an M232R substitution: report of a patient showing slowly progressive disease with abundant plaque-like PrP deposits in the cerebellum. Neuropathology 29:735–743PubMedCrossRef Shimizu H, Yamada M, Matsubara N et al (2009) Creutzfeldt–Jakob disease with an M232R substitution: report of a patient showing slowly progressive disease with abundant plaque-like PrP deposits in the cerebellum. Neuropathology 29:735–743PubMedCrossRef
150.
Zurück zum Zitat Skworc KH, Windl O, Schulz-Schaeffer WJ et al (1999) Familial Creutzfeldt–Jakob disease with a novel 120-bp insertion in the prion protein gene. Ann Neurol 46:693–700CrossRef Skworc KH, Windl O, Schulz-Schaeffer WJ et al (1999) Familial Creutzfeldt–Jakob disease with a novel 120-bp insertion in the prion protein gene. Ann Neurol 46:693–700CrossRef
151.
Zurück zum Zitat Silvestrini MC, Cardone F, Maras B et al (1997) Identification of the prion protein allotypes which accumulate in the brain of sporadic and familial Creutzfeldt–Jakob disease patients. Nat Med 3:521–525PubMedCrossRef Silvestrini MC, Cardone F, Maras B et al (1997) Identification of the prion protein allotypes which accumulate in the brain of sporadic and familial Creutzfeldt–Jakob disease patients. Nat Med 3:521–525PubMedCrossRef
152.
Zurück zum Zitat Soldevila M, Calafell F, Andrés AM et al (2003) Prion susceptibility and protective alleles exhibit marked geographic differences. Hum Mutat 22:104–105PubMedCrossRef Soldevila M, Calafell F, Andrés AM et al (2003) Prion susceptibility and protective alleles exhibit marked geographic differences. Hum Mutat 22:104–105PubMedCrossRef
153.
Zurück zum Zitat Stahl N, Baldwin MA, Burlingame AL, Prusiner SB (1990) Identification of glycoinositol phospholipid linked and truncated forms of the scrapie prion protein. Biochemistry 29:8879–8884PubMedCrossRef Stahl N, Baldwin MA, Burlingame AL, Prusiner SB (1990) Identification of glycoinositol phospholipid linked and truncated forms of the scrapie prion protein. Biochemistry 29:8879–8884PubMedCrossRef
154.
Zurück zum Zitat Stern K (1939) Severe dementia associated with bilateral symmetrical degeneration of the thalamus. Brain 62:157–171CrossRef Stern K (1939) Severe dementia associated with bilateral symmetrical degeneration of the thalamus. Brain 62:157–171CrossRef
155.
Zurück zum Zitat Swietnicki W, Petersen SB, Gambetti P, Surewicz WK (1998) Familial mutations and the thermodynamic stability of the recombinant human prion protein. J Biol Chem 273:31048–31052PubMedCrossRef Swietnicki W, Petersen SB, Gambetti P, Surewicz WK (1998) Familial mutations and the thermodynamic stability of the recombinant human prion protein. J Biol Chem 273:31048–31052PubMedCrossRef
156.
Zurück zum Zitat Tateishi J, Brown P, Kitamoto T et al (1995) First experimental transmission of fatal familial insomnia. Nature 376:434–435PubMedCrossRef Tateishi J, Brown P, Kitamoto T et al (1995) First experimental transmission of fatal familial insomnia. Nature 376:434–435PubMedCrossRef
157.
Zurück zum Zitat Telling GC, Parchi P, DeArmond SJ et al (1996) Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274:2079–2082PubMedCrossRef Telling GC, Parchi P, DeArmond SJ et al (1996) Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274:2079–2082PubMedCrossRef
158.
Zurück zum Zitat Vetrugno V, Malchow M, Liu Q, Marziali G, Battistini A, Pocchiari M (1999) Expression of wild-type and V210I mutant prion protein in human neuroblastoma cells. Neurosci Lett 270:41–44PubMedCrossRef Vetrugno V, Malchow M, Liu Q, Marziali G, Battistini A, Pocchiari M (1999) Expression of wild-type and V210I mutant prion protein in human neuroblastoma cells. Neurosci Lett 270:41–44PubMedCrossRef
159.
Zurück zum Zitat Watanabe Y, Hiraoka W, Shimoyama Y, Horiuchi M, Kuwabara M, Inanami O (2008) Instability of familial spongiform encephalopathy-related prion mutants. Biochem Biophys Res Commun 366:244–249PubMedCrossRef Watanabe Y, Hiraoka W, Shimoyama Y, Horiuchi M, Kuwabara M, Inanami O (2008) Instability of familial spongiform encephalopathy-related prion mutants. Biochem Biophys Res Commun 366:244–249PubMedCrossRef
160.
Zurück zum Zitat Weissmann C, Flechsig E (2003) PrP knock-out and PrP transgenic mice in prion research. Br Med Bull 66:43–60PubMedCrossRef Weissmann C, Flechsig E (2003) PrP knock-out and PrP transgenic mice in prion research. Br Med Bull 66:43–60PubMedCrossRef
161.
Zurück zum Zitat Windl O, Dempster M, Estibeiro JP et al (1996) Genetic basis of Creutzfeldt–Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum Genet 98:259–264PubMedCrossRef Windl O, Dempster M, Estibeiro JP et al (1996) Genetic basis of Creutzfeldt–Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum Genet 98:259–264PubMedCrossRef
162.
Zurück zum Zitat Ye J, Han J, Shi Q et al (2008) Human prion disease with a G114V mutation and epidemiological studies in a Chinese family: a case series. J Med Case Reports 2:331PubMedCrossRef Ye J, Han J, Shi Q et al (2008) Human prion disease with a G114V mutation and epidemiological studies in a Chinese family: a case series. J Med Case Reports 2:331PubMedCrossRef
163.
Zurück zum Zitat Yoshida H, Terada S, Ishizu H et al (2010) An autopsy case of Creutzfeldt–Jakob disease with a V180I mutation of the PrP gene and Alzheimer-type pathology. Neuropathology 30:159–164PubMedCrossRef Yoshida H, Terada S, Ishizu H et al (2010) An autopsy case of Creutzfeldt–Jakob disease with a V180I mutation of the PrP gene and Alzheimer-type pathology. Neuropathology 30:159–164PubMedCrossRef
164.
Zurück zum Zitat Zahn R, Liu A, Luhrs T, Riek R et al (2000) NMR solution structure of the human prion protein. Proc Natl Acad Sci USA 97:145–150PubMedCrossRef Zahn R, Liu A, Luhrs T, Riek R et al (2000) NMR solution structure of the human prion protein. Proc Natl Acad Sci USA 97:145–150PubMedCrossRef
165.
Zurück zum Zitat Zhang Y, Swietnicki W, Zagorski MG, Surewicz WK, Sonnichsen FD (2000) Solution structure of the E200K variant of human prion protein. J Biol Chem 275:33650–33654PubMedCrossRef Zhang Y, Swietnicki W, Zagorski MG, Surewicz WK, Sonnichsen FD (2000) Solution structure of the E200K variant of human prion protein. J Biol Chem 275:33650–33654PubMedCrossRef
166.
Zurück zum Zitat Zou WQ, Capellari S, Parchi P, Sy MS, Gambetti P, Chen SG (2003) Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt–Jakob disease. J Biol Chem 278:40429–40436PubMedCrossRef Zou WQ, Capellari S, Parchi P, Sy MS, Gambetti P, Chen SG (2003) Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt–Jakob disease. J Biol Chem 278:40429–40436PubMedCrossRef
167.
Zurück zum Zitat Zuegg J, Gready JE (1999) Molecular dynamics simulations of human prion protein: importance of correct treatment of electrostatic interactions. Biochemistry 38:13862–13876PubMedCrossRef Zuegg J, Gready JE (1999) Molecular dynamics simulations of human prion protein: importance of correct treatment of electrostatic interactions. Biochemistry 38:13862–13876PubMedCrossRef
Metadaten
Titel
Genetic Creutzfeldt–Jakob disease and fatal familial insomnia: insights into phenotypic variability and disease pathogenesis
verfasst von
Sabina Capellari
Rosaria Strammiello
Daniela Saverioni
Hans Kretzschmar
Piero Parchi
Publikationsdatum
01.01.2011
Verlag
Springer-Verlag
Erschienen in
Acta Neuropathologica / Ausgabe 1/2011
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-010-0760-4

Weitere Artikel der Ausgabe 1/2011

Acta Neuropathologica 1/2011 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Neu im Fachgebiet Neurologie

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.